A partial fill lets a pharmacy dispense less than the full quantity a prescription authorizes, then complete the balance within a fixed federal window. The dispensing rule is straightforward on paper. The billing that follows it is where independent pharmacies most often lose ground on a PBM audit. Two claims tied to one prescription, submitted days or weeks apart, create exactly the kind of quantity and days-supply mismatch that PBM audit software is built to flag, and a completion fill billed after the federal window has closed compounds the exposure into a full recoupment demand.
Completion Windows Under Federal Law
The completion deadline for a partial fill depends on why it happened and what schedule the drug carries. Under 21 CFR 1306.13(a), when a pharmacist cannot supply the full quantity of a Schedule II prescription, the remaining portion must be dispensed within 72 hours or the pharmacist must notify the prescriber, and no further quantity may go out without a new prescription. When the patient or prescriber requests a partial fill of a Schedule II drug rather than the pharmacy being short, the remainder has up to 30 days to be completed (72 hours for an emergency oral prescription), and long-term care or terminally ill patients get up to 60 days. Schedule III, IV, and V prescriptions run on a longer clock: under 21 CFR 1306.23, partial fillings may continue as long as the total quantity dispensed never exceeds what was prescribed and no dispensing occurs more than six months after the prescription was issued.
Where the Billing Diverges From the Dispensing
Each partial fill is a separate dispensing event, and PBM claims adjudication expects a separate claim for each one, billed for only the quantity and days supply actually handed to the patient that day. The recurring error is billing the full prescribed quantity on the first partial fill and then submitting a second claim for the completion fill days later. That pattern reads to an auditor as duplicate billing for the same prescription rather than as two halves of one authorized dispensing. Days supply compounds the problem: if the days supply on the first claim reflects the full prescription instead of the partial quantity dispensed, the completion claim can trip a refill-too-soon rejection or an overbilled-quantity flag on the pharmacy's own adjudication log, and a single arithmetic error at the point of sale becomes two separate audit findings by the time the prescription is closed out.
Common Findings on Partial-Fill Claims
PBM audits of partial fills tend to surface the same handful of discrepancies. A completion fill billed after the applicable federal window closed, with nothing in the record showing the pharmacy notified the prescriber or obtained a new prescription, gets treated as an undocumented dispensing rather than a lawful completion. A total dispensed quantity across both claims that does not match the original prescription, even by a small margin, is flagged as an inventory shortfall or an overbilled claim regardless of which direction the error runs. And a pharmacy that cannot produce the partial-fill notation the DEA already requires, the date, quantity dispensed, quantity remaining, and dispensing pharmacist for each fill, has no record to reconcile against the PBM's own claim adjudication log when the two do not line up.
The DEA's partial-fill documentation and the PBM's billed claim are supposed to describe the same transaction. When they do not match, the pharmacy is defending two records instead of one.
Why Early Legal Counsel Is Critical
It is critical that pharmacies retain experienced healthcare defense counsel promptly upon receiving a PBM audit notice that flags partial-fill claims. Early legal intervention can protect the pharmacy's rights, ensure the audit response reconciles the DEA-required partial-fill documentation with the billed claims before the PBM's deadline runs, avoid inadvertent admissions in written correspondence, and preserve the pharmacy's position on an audit appeal if the finding is not resolved at the first level. Delaying counsel until after a response deadline has passed can foreclose defenses, including documentation the pharmacy already had on file, that were available at the outset.
How Health Law Alliance Can Help
Health Law Alliance defends pharmacies nationwide against PBM audit findings built on partial-fill and days-supply discrepancies, including findings that escalate toward network termination. Our bench includes a former federal prosecutor and a former senior pharmacy benefit manager executive, background that shapes how we reconcile a pharmacy's dispensing record against the PBM's claims data. For the broader mechanics of responding to a notice, see our companion guide on how to respond to a PBM audit letter. If your pharmacy has received an audit notice citing partial-fill claims, contact us for a free, confidential consultation.
